Xu, Ping <br/><br/>
shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.  [electronic resource] 

 -  International journal of clinical and experimental pathology  2015 
 - 2300-10 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1936-2625 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B--genetics<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--metabolism<br/>Breast Neoplasms--chemistry<br/>Calcium-Binding Proteins--genetics<br/>Cell Cycle Checkpoints--drug effects<br/>Cell Cycle Proteins--metabolism<br/>Cell Proliferation--drug effects<br/>Cisplatin--pharmacology<br/>Dose-Response Relationship, Drug<br/>Doxorubicin--pharmacology<br/>Drug Resistance, Neoplasm--genetics<br/>Gene Expression Regulation, Neoplastic<br/>Glioma--chemistry<br/>Hep G2 Cells<br/>Humans<br/>Multidrug Resistance-Associated Proteins--genetics<br/>Multiple Myeloma--drug therapy<br/>RNA Interference<br/>RNA, Small Interfering--genetics<br/>Rhodamine 123--metabolism<br/>Signal Transduction--drug effects<br/>Transfection